Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Gowling WLG (Canada) LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Entrectinib

Brand Name : ROZLYTREK

Patent Number : 2693901

Filing Date : 2008-07-08

Strength per Unit : 100 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-07-08

Date Granted : 2015-12-29

blank

02

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Entrectinib

Brand Name : ROZLYTREK

Patent Number : 2873979

Filing Date : 2013-05-22

Strength per Unit : 100 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-05-22

Date Granted : 2019-11-12

blank

03

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Entrectinib

Brand Name : ROZLYTREK

Patent Number : 2693901

Filing Date : 2008-07-08

Strength per Unit : 200 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-07-08

Date Granted : 2015-12-29

blank

04

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Entrectinib

Brand Name : ROZLYTREK

Patent Number : 2873979

Filing Date : 2013-05-22

Strength per Unit : 200 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-05-22

Date Granted : 2019-11-12

blank

05

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Entrectinib

Brand Name : ROZLYTREK

Patent Number : 2933623

Filing Date : 2015-02-19

Strength per Unit : 100 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-02-19

Date Granted : 2022-05-17

blank

06

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Entrectinib

Brand Name : ROZLYTREK

Patent Number : 3024208

Filing Date : 2017-05-18

Strength per Unit : 100 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2037-05-18

Date Granted : 2022-07-26

blank

07

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Entrectinib

Brand Name : ROZLYTREK

Patent Number : 2933623

Filing Date : 2015-02-19

Strength per Unit : 200 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-02-19

Date Granted : 2022-05-17

blank

08

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Entrectinib

Brand Name : ROZLYTREK

Patent Number : 3024208

Filing Date : 2017-05-18

Strength per Unit : 200 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2037-05-18

Date Granted : 2022-07-26

blank